CJC-1295 with DAC
Also known as CJC-1295 DAC
A DAC-modified GHRH analog studied for extended activity in endocrine research models.
What it is
CJC-1295 with DAC is a modified GHRH analog carrying a drug affinity complex (DAC) that binds albumin, which the research literature associates with a substantially longer functional half-life than the non-DAC form. The DAC modification is the defining feature that separates it from plain CJC-1295 / mod-GRF.
How it is studied
It is studied in endocrine research models examining sustained GHRH-receptor signaling, often compared against shorter-acting GHRH analogs and the non-DAC form. It is supplied strictly as a research compound.
Purity and COA
Our COA states the DAC modification explicitly and confirms sequence and modification by mass spectrometry, with HPLC purity for the specific batch.
Further reading
Search the primary literature and registered studies for CJC-1295 with DAC on independent research databases. LNK is not affiliated with these sources and does not endorse their conclusions.